This difference in cost according to age was also true for the subset of patients with Hb SS or HbSβ0-thalassemia, in which median hospitalization costs among children were higher than those for adults ($1885.37 versus $1369.55 per hospitalization, respectively, p = 0.0008). The gene discussed is GSTM1; the disease is thalassemia.